PIC/S GMP manufacturing facility

 

  

Ever Supreme was granted approval by the Ministry of Science and Technology (MoST) in Taiwan in February of 2017 for setting up the manufacturing pharmaceutical base in the Central Taiwan Science Park (CTSP).

For ensuring the quality, Ever Supreme invested more than NT$100 million in building and the construction is expected to be completed by end of 2017, and will start an early trial production in 2018.